Management of dyskinesia in COMT-naive patients starting adjunctive therapy with opicapone: the BIPARK-I double-blind experience

被引：0
|
作者：
Pagonabarraga, J. [1 ]
Tolosa, E. [2 ]
Ferreira, J. [3 ]
Lees, A. [4 ]
Arbe, E. [5 ]
Rocha, J. [5 ]
Soares-Da-Silva, P. [6 ]
机构：
[1] Hosp Santa Creu & Sant Pau, Unit Movement Disorders, Neurol, Barcelona, Spain
[2] Hosp Clin Univ Barcelona, Parkinson Dis & Movement Disorder Unit, Barcelona, Spain
[3] Inst Med Mol, Neurol Clin Res Unit, Lisbon, Portugal
[4] Natl Hosp Neurol & Neurosurg, London, England
[5] BIAL Portela & Co SA, Global Parkinson Dis, Sao Mamede do Coronado, Portugal
[6] BIAL Portela & Co SA, Res & Dev, Sao Mamede do Coronado, Portugal
来源：
EUROPEAN JOURNAL OF NEUROLOGY | 2018年 / 25卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
EPR3069
引用
收藏
页码：516 / 516
页数：1
相关论文
共 50 条
  • [21] Efficacy of Opicapone as First-Line Adjunctive Levodopa Treatment in Parkinson's Disease Patients with Motor Fluctuations: a Post-Hoc Analysis from Double-Blind Combined BIPARK-I and II Data
    Hauser, Robert
    Ferreira, Joaquim J.
    Poewe, Werner
    Antonini, Angelo
    Rocha, Jose-Francisco
    Magalhaes, Diogo
    Soares-da-Silva, Patricio
    Klepitskaya, Olga
    Liang, Grace
    NEUROLOGY, 2020, 94 (15)
  • [22] SWITCHING FROM DOUBLE-BLIND ENTACAPONE OR PLACEBO TO OPEN-LABEL OPICAPONE: NMSS RESULTS (1-YEAR EXTENSION BIPARK-I STUDY)
    Fabregues, O.
    Tolosa, E.
    Ferreira, J.
    Lees, A.
    Santos, A.
    Rocha, J.
    Soares-Da-Silva, P.
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2019, 90 (12): : E49 - E49
  • [23] Switching from double-blind entacapone or placebo to open-label opicapone: NMSS results of the 1-year extension BIPARK-I study
    Fabregues, O.
    Tolosa, E.
    Ferreira, J.
    Lees, A.
    Santos, A.
    Arbe, E.
    Rocha, J-F.
    Soares-da-Silva, P.
    MOVEMENT DISORDERS, 2018, 33 : S142 - S142
  • [24] Dopaminergic adverse-events in patients that switched from entacapone to opicapone: the BIPARK-I open-label experience
    Ceballos-Baumann, A.
    Eggert, K.
    Ferreira, J.
    Poewe, W.
    Rascol, O.
    Arbe, E.
    Rocha, J.
    Soares-Da-Silva, P.
    EUROPEAN JOURNAL OF NEUROLOGY, 2018, 25 : 428 - 428
  • [25] Switching from double-blind entacapone or placebo to open-label opicapone: change in OFF-/ON-time from patients who ended the 1-year BIPARK-I extension on opicapone 50 mg
    Ferreira, J.
    Lees, A.
    Rascol, O.
    Poewe, W.
    Ikedo, F.
    Magalhaes, D.
    Rocha, F.
    Soares-da-Silva, P.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2019, 405
  • [26] Occurrence of dopaminergic adverse-events in patients that switched from entacapone to opicapone: The BIPARK-I open-label experience
    Ceballos-Baumann, A.
    Eggert, K.
    Ferreira, J.
    Poewe, W.
    Rascol, O.
    Arbe, E.
    Rocha, J-F
    Soares-da-Silva, P.
    MOVEMENT DISORDERS, 2018, 33 : S131 - S131
  • [27] Switching from double-blind entacapone or placebo to open-label opicapone: UPDRS-II and III results from patients who ended 1-year BIPARK-I extension on opicapone 50 mg
    Rocha, F.
    Ferreira, J.
    Lees, A.
    Tolosa, E.
    Stocchi, F.
    Santos, A.
    Magalhaes, D.
    Soares-da-Silva, P.
    Savic, N.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2019, 405
  • [28] Switching from double-blind entacapone or placebo to open-label opicapone: UPDRS-II and III results of the 1-year extension BIPARK-I study
    Ehret, R.
    Ferreira, J.
    Stocchi, F.
    Ikedo, F.
    Arbe, E.
    Rocha, J-F.
    Soares-da-Silva, P.
    MOVEMENT DISORDERS, 2018, 33 : S102 - S102
  • [29] Efficacy of opicapone in Parkinson's disease patients according to baseline presence of dyskinesia: A post-hoc analysis from combined BIPARK-I and II
    Lees, A.
    Ferreira, J.
    Antonini, A.
    Reichmann, H.
    Costa, R.
    Magalhaes, D.
    Rocha, F.
    Soares-da-Silva, P.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2019, 405
  • [30] Switch of double-blind opicapone, entacapone or placebo to open-label opicapone: efficacy results of the 1-year extension of study BIPARK I
    Ferreira, J.
    Lees, A.
    Tolosa, E.
    Poewe, W.
    Banach, M.
    Santos, A.
    Lopes, N.
    Rocha, J. F.
    Soares-Da-Silva, P.
    EUROPEAN JOURNAL OF NEUROLOGY, 2016, 23 : 393 - 393
12345